Direct Molecular Detection and Genotyping of Borrelia burgdorferi from Whole Blood of Patients with Early Lyme Disease

• Mark W. Eshoo ,

  * E-mail: *mark.eshoo@abbott.com

  Affiliation Ibis Biosciences Inc., an Abbott Company, Carlsbad, California, United States of America

  ⨯
• Christopher C. Crowder,

  Affiliation Ibis Biosciences Inc., an Abbott Company, Carlsbad, California, United States of America

  ⨯
• Alison W. Rebman,

  Affiliation Lyme Disease Research Foundation, Lutherville, Maryland, United States of America

  ⨯
• Megan A. Rounds,

  Affiliation Ibis Biosciences Inc., an Abbott Company, Carlsbad, California, United States of America

  ⨯
• Heather E. Matthews,

  Affiliation Ibis Biosciences Inc., an Abbott Company, Carlsbad, California, United States of America

  ⨯
• John M. Picuri,

  Affiliation Ibis Biosciences Inc., an Abbott Company, Carlsbad, California, United States of America

  ⨯
• Mark J. Soloski,

  Affiliation Divisions of Rheumatology and Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• David J. Ecker,

  Affiliation Ibis Biosciences Inc., an Abbott Company, Carlsbad, California, United States of America

  ⨯
• Steven E. Schutzer,

  Affiliation Department of Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey, United States of America

  ⨯
• John N. Aucott

  Affiliation Divisions of Rheumatology and Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  ⨯